Alimera Sciences (ALIM) Misses Q1 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/30/2026
- S&P 500 dips, Nasdaq higher on modest rise in inflation
- Equity positioning stays overweight, but summer extremes have eased: Barclays
- Oil prices rise by about $1/bbl on stalled US-Iran talks and tight fuel markets
- Micron reports Q4 today: Why Lynx Equity sees massive upside
- Moderna: Citi says oncology optimism is priced in, cuts rating to sell
- Salesforce agrees to acquire AI research platform Listen Labs
- Workday cuts 2.5% of workforce, revises GAAP margin outlook
- Zimbabwe helicopter crash kills six, government spokesperson says
- Apple's iOS 27 is blocking Trade Desk ads on Safari, analyst says
- S&P 500 flat as higher bond yields counter tech optimism
Cowen Downgrades Alimera Sciences (ALIM) to Market Perform
May 6, 2016 6:47 AM EDTCowen downgraded Alimera Sciences (NASDAQ: ALIM) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Alimera Sciences click here. For more ratings news on Alimera Sciences click here.
Shares of Alimera Sciences closed at $1.92 yesterday.
... More